Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Frequent use of continuous glucose monitoring (CGM) systems is associated with improved glycemic outcomes in persons with diabetes, but the need for calibrations and sensor insertions are often barriers to adoption. In this study, we evaluated the performance of G6, a sixth-generation, factory-calibrated CGM system specified for 10-day wear. METHODS: The study enrolled participants of ages 6 years and up with type 1 diabetes or insulin-treated type 2 diabetes at 11 sites in the United States. Participation involved one sensor wear period of up to 10 days. Adults wore the system on the abdomen; youth of ages 6-17 years could choose to wear it on the abdomen or upper buttocks. Clinic sessions for frequent comparison with reference blood glucose measurements took place on days 1, 4-5, 7, and/or 10. Participants of ages 13 years and up underwent purposeful supervised glucose manipulation during in-clinic sessions. During the study, participants calibrated the systems once daily. However, analysis was performed on glucose values that were derived from reprocessed raw sensor data, independently of self-monitored blood glucose values used for calibration. Reprocessing used assigned sensor codes and a factory-calibration algorithm. Performance evaluation included the proportion of CGM values that were within ±20% of reference glucose values >100 mg/dL or within ±20 mg/dL of reference glucose values ≤100 mg/dL (%20/20), the analogous %15/15, and the mean absolute relative difference (MARD, expressed as a percentage) between temporally matched CGM and reference values. RESULTS: Data from 262 study participants (21,569 matched CGM reference pairs) were analyzed. The overall %15/15, %20/20, and MARD were 82.4%, 92.3%, and 10.0%, respectively. Matched pairs from 134 adults and 128 youth of ages 6-17 years were similar with respect to %20/20 (92.4% and 91.9%) and MARD (9.9% and 10.1%). Overall %20/20 values on days 1 and 10 of sensor wear were 88.6% and 90.6%, respectively. The system's "Urgent Low Soon" (predictive of hypoglycemia within 20 min) hypoglycemia alert was correctly provided 84% of the time within 30 min before impending biochemical hypoglycemia (<70 mg/dL). The 10-day sensor survival rate was 87%. CONCLUSION: The new factory-calibrated G6 real-time CGM system provides accurate readings for 10 days and removes several clinical barriers to broader CGM adoption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069
Self-citationBeck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., et al. (2017) · JAMA · doi:10.1001/jama.2016.19976 · Cited by 705
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635
Agiostratidou, G., Anhalt, H., Ball, D., Blonde, L., Gourgari, E., Harriman, K. N., Kowalski, A. J., Madden, P., McAuliffe-Fogarty, A. H., McElwee-Malloy, M., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1624 · Cited by 397
Polonsky, W. H., Hessler, D., Ruedy, K. J., & Beck, R. W. (2017) · Diabetes Care · doi:10.2337/dc17-0133 · Cited by 346
Reddy, M., Jugnee, N., El Laboudi, A., Spanudakis, E., Anantharaja, S., & Oliver, N. (2018) · Diabetic Medicine · doi:10.1111/dme.13561 · Cited by 245
Freckmann, G., Schmid, C., Baumstark, A., Pleus, S., Link, M., & Haug, C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600510 · Cited by 237
Ruedy, K. J., Parkin, C. G., Riddlesworth, T. D., & Graham, C. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817704445 · Cited by 225
Ólafsdóttir, A. F., Attvall, S., Sandgren, U., Dahlqvist, S., Pivodic, A., Skrtic, S., Theodorsson, E., & Lind, M. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0392 · Cited by 173
Cited by
Electrochemical glucose sensors in diabetes management: an updated review (2010–2020)
Teymourian, H., Barfidokht, A., & Wang, J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00304b · Cited by 881
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Battelino, T., Alexander, C. M., Amiel, S. A., Arreaza-Rubin, G., Beck, R. W., Bergenstal, R. M., Buckingham, B. A., Carroll, J., Ceriello, A., Chow, E., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00319-9 · Cited by 831
Self-citationMeasures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices
Freckmann, G., Pleus, S., Grady, M., Setford, S., & Levy, B. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818812062 · Cited by 202
Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes
Garg, S. K., Kipnes, M., Castorino, K., Bailey, T. S., Akturk, H. K., Welsh, J. B., Christiansen, M. P., Balo, A. K., Brown, S. A., Reid, J. L., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0011 · Cited by 179
Self-citationHeinemann, L., Schoemaker, M., Schmelzeisen-Redecker, G., Hinzmann, R., Kassab, A., Freckmann, G., Reiterer, F., & Del Re, L. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819855670 · Cited by 170
Alva, S., Bailey, T., Brazg, R., Budiman, E. S., Castorino, K., Christiansen, M. P., Forlenza, G., Kipnes, M., Liljenquist, D. R., & Liu, H. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820958754 · Cited by 164
A clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm
Messer, L. H., Berget, C., & Forlenza, G. P. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0105 · Cited by 100
Freckmann, G., Eichenlaub, M., Waldenmaier, D., Pleus, S., Wehrstedt, S., Haug, C., Witthauer, L., Jendle, J., Hinzmann, R., Thomas, A., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231190941 · Cited by 86
“90,96,123,127,131,138,140,155,158,160 However, this cannot be recommended as the CGM value distribution is dependent on CGM accuracy and thus impairs the comparison of testing procedures among studies.”
BackgroundImproved Real-World Glycemic Control With Continuous Glucose Monitoring System Predictive Alerts
Abraham, S. B., Arunachalam, S., Zhong, A., Agrawal, P., Cohen, O., & McMahon, C. M. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819859334 · Cited by 63
Merino, J., Linenberg, I., Bermingham, K. M., Ganesh, S., Bakker, E., Delahanty, L. M., Chan, A. T., Capdevila Pujol, J., Wolf, J., Al Khatib, H., et al. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac026 · Cited by 46
Pemberton, J. S., Wilmot, E. G., Barnard‐Kelly, K., Leelarathna, L., Oliver, N., Randell, T., Taplin, C. E., Choudhary, P., & Adolfsson, P. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14962 · Cited by 44
“The iCGM accuracy performance standards are met for adults and comparability is achieved in paediatrics for the Dexcom ONETM, as it uses the same sensor and algorithm as the Dexcom G6TM.(11,12) For adults, the GuardianTM Sensor 3 combined with the MiniMed GuardianTM Connect System does not meet two of the seven standa…”
MethodInaccurate glucose sensor values after hydroxyurea administration
Tellez, S. E., Hornung, L. N., Courter, J. D., Abu-El-Haija, M., Nathan, J. D., Lawson, S. A., & Elder, D. A. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0490 · Cited by 33
“13 In addition, the Dexcom G6 system demonstrated consistent performance in all participants, including pediatric patients, even during times in which glucose concentrations are rising or falling, and throughout the duration of the sensor.”
Distinct patterns of daily glucose variability by pubertal status in youth with type 1 diabetes
Zhu, J., Volkening, L. K., & Laffel, L. M. (2020) · Diabetes Care · doi:10.2337/dc19-0083 · Cited by 30
Self-citationCummings, C., Jiang, A., Sheehan, A., Ferraz‐Bannitz, R., Puleio, A., Simonson, D. C., Dreyfuss, J. M., & Patti, M. E. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15096 · Cited by 27
Baker, M., Musselman, M. E., Rogers, R., & Hellman, R. (2022) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxab456 · Cited by 27
Ji, L., Guo, L., Zhang, J., Li, Y., & Chen, Z. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211037991 · Cited by 26
A Head-to-Head Comparison Study of the First-Day Performance of Two Factory-Calibrated CGM Systems
Denham, D. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819895505 · Cited by 18
Hochfellner, D. A., Simic, A., Taucher, M. T., Sailer, L. S., Kopanz, J., Pöttler, T., & Mader, J. K. (2022) · Biosensors · doi:10.3390/bios12020106 · Cited by 15
Metadata
- Authors
- Wadwa, R. P., Laffel, L. M., Shah, V. N., & Garg, S. K.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2018-06
- Volume
- 20
- Issue
- 6
- Pages
- 395-402
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2807723223
- Cited by
- 198
- References
- 13
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.